Filing Details

Accession Number:
0001127602-12-009534
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-05 16:01:59
Reporting Period:
2012-03-01
Filing Date:
2012-03-05
Accepted Time:
2012-03-05 16:01:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946840 Viropharma Inc VPHM Pharmaceutical Preparations (2834) 232789550
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383292 Jr A Charles Rowland 730 Stockton Drive
Exton PA 19341
Vp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-01 35,000 $11.96 64,875 No 4 M Direct
Common Stock Acquisiton 2012-03-01 10,000 $5.91 74,875 No 4 M Direct
Common Stock Acquisiton 2012-03-01 25,000 $8.86 99,875 No 4 M Direct
Common Stock Disposition 2012-03-01 70,000 $32.12 29,875 No 4 S Direct
Common Stock Disposition 2012-03-01 12,750 $32.11 17,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-03-01 35,000 $0.00 35,000 $11.96
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-03-01 10,000 $0.00 10,000 $5.91
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-03-01 25,000 $0.00 25,000 $8.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,000 2009-10-20 2018-10-20 No 4 M Direct
20,000 2010-06-11 2019-06-11 No 4 M Direct
50,000 2011-01-07 2020-01-07 No 4 M Direct
Footnotes
  1. These options vest in four equal annual installments beginning on the first anniversary date from time of grant.
  2. The options vest in four equal annual installments beginning on the first anniversary date from time of grant.
  3. The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $32.10 to $32.16, inclusive.
  4. The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $32.03 to $32.15, inclusive.